PROMOTING ACCESS TO AFRICAN RESEARCH

African Health Sciences

Log in or Register to get access to full text downloads.

Remember me or Register

Methylenetetrahydrofolate Reductase C677T polymorphism and breast cancer risk in Moroccan women

B Diakite, A Tazzite, K Hamzi, H Jouhadi, S Nadifi

Abstract


Background: Methylenetetrahydrofolate (MTHFR) enzyme plays an important role in folate metabolism which is involved in DNA methylation, repair, and synthesis.
Objective: We investigated if the MTHFR C677T polymorphism modulates the risk of developing breast cancer in Moroccan women.
Methods: Genotyping was performed by PCR-RFLP method on a sample of 96 patients with breast cancer and 117 controls.
Results: A positive correlation was found between the MTHFR C677T polymorphism and progesterone receptors expression (p= 0.04). According to menopausal status, the heterozygous CT (OR = 2.29 and P = 0.03) was statistically significant in pre-menopausal women. There was a significant association between C677T polymorphism and breast cancer risk in both additive (OR = 2.2, 95% CI = 1.24-3.86, p = 0.007) and dominant (OR = 2.10, CI 95% = 1.21-3.64, p = 0.008) models. In addition, the T allele were associated with a high breast cancer risk (OR = 1.59, 95% CI = 1.04-2.44, p = 0.03).                                                             Conclusion: In the light of our preliminary study, 677T allele and 677CT MTHFR genotype may represent a genetic determinant increasing breast cancer risk in Moroccan women. A larger study including a larger sample size and more information is needed to confirm our conclusions.

Key words: MTHFR polymorphism, breast neoplasm, Morocco.


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


http://dx.doi.org/10.4314/ahs.v12i2.20

African Health Sciences.   ISSN: 1680-6905
AJOL African Journals Online